Pharm Exec Podcast
Pharmaceutical Executive Daily: September 17, 2025
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:02:36
- Mas informaciones
Informações:
Sinopsis
In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, Merck and Daiichi Sankyo’s breakthrough therapy designation for R-DXd in ovarian cancer, and Novo Nordisk’s EU approval of Rybelsus for reducing cardiovascular risk.
